损坏的α-TTP-PIPs相互作用是家族维生素E缺乏症的基础
Nozomu Kono1, Umeharu Ohto, Tatsufumi Hiramatsu
1Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
Science (New York, N.Y.)
|April 20, 2013
概括
酸丁酸酸盐 (PIPs) 与α-托科菲罗尔 (维生素E) 转移蛋白 (α-TTP) 结合,促进维生素E的分泌. 这种结合打开了α-TTP连接体结合口袋,澄清了氨酸残留在维生素E缺乏症中的作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 阿尔法-托科菲罗 (维生素E) 转移蛋白 (α-TTP) 对于从肝细胞分泌维生素E至关重要.
- 在α-TTP中发生的误解突变,特别是在表面的氨酸残留物中,会导致严重的维生素E缺乏,但它们的确切功能仍然不清楚.
研究的目的:
- 为了研究酸盐酸盐 (PIPs) 在α-TTP功能中的作用.
- 阐明α-TTP中阿尔金因突变导致维生素E缺乏症的机制.
主要方法:
- 结合性测试用于检测野生类型α-TTP,阿金宁突变体和PIPs之间的相互作用.
- 脂质转移试验测量由PIPs促进的α-托哥法醇转移.
- 对α-TTP-PIPs复合物的晶体结构分析.
主要成果:
- 野生类型的α-TTP证明与PIP结合,而阿金宁突变体没有显示这种相互作用.
- 在目标膜中存在的PIPs显著促进了α-TTP介导的α-托科菲罗尔的膜间转移.
- 晶体结构显示,与疾病相关的氨酸残留物与PIP酸群直接相互作用,诱导构造变化,打开α-托科菲罗尔结合口袋.
结论:
- PIPs在增强α-TTP释放α-托科菲罗尔方面发挥着至关重要的作用.
- PIP和特定的氨酸残留物之间的相互作用对于α-TTP在维生素E分泌中的功能至关重要.
- 了解这种机制可以了解由α-TTP突变引起的维生素E缺乏的分子基础.
相关概念视频
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:35Pedigree Analysis
Overview
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...